203 related articles for article (PubMed ID: 8098030)
1. Predicting the long-term risk of tardive dyskinesia in outpatients maintained on neuroleptic medications.
Glazer WM; Morgenstern H; Doucette JT
J Clin Psychiatry; 1993 Apr; 54(4):133-9. PubMed ID: 8098030
[TBL] [Abstract][Full Text] [Related]
2. Identifying risk factors for tardive dyskinesia among long-term outpatients maintained with neuroleptic medications. Results of the Yale Tardive Dyskinesia Study.
Morgenstern H; Glazer WM
Arch Gen Psychiatry; 1993 Sep; 50(9):723-33. PubMed ID: 8102845
[TBL] [Abstract][Full Text] [Related]
3. Handedness and the risk of tardive dyskinesia.
Morgenstern H; Glazer WM; Doucette JT
Biol Psychiatry; 1996 Jul; 40(1):35-42. PubMed ID: 8780853
[TBL] [Abstract][Full Text] [Related]
4. High incidence of tardive dyskinesia in older outpatients on low doses of neuroleptics.
Harris MJ; Panton D; Caligiuri MP; Krull AJ; Tran-Johnson TK; Jeste DV
Psychopharmacol Bull; 1992; 28(1):87-92. PubMed ID: 1609047
[TBL] [Abstract][Full Text] [Related]
5. Tardive dyskinesia in outpatients on depot phenothiazine.
Neehall J
West Indian Med J; 1989 Dec; 38(4):228-33. PubMed ID: 2576166
[TBL] [Abstract][Full Text] [Related]
6. Tardive dyskinesia: managing a common neuroleptic side effect.
Jeste DV; Krull AJ; Kilbourn K
Geriatrics; 1990 Dec; 45(12):49-54. PubMed ID: 1979304
[TBL] [Abstract][Full Text] [Related]
7. The natural history of tardive dyskinesia.
Gardos G; Cole JO; Haskell D; Marby D; Paine SS; Moore P
J Clin Psychopharmacol; 1988 Aug; 8(4 Suppl):31S-37S. PubMed ID: 2906068
[TBL] [Abstract][Full Text] [Related]
8. Review of incidence studies of tardive dyskinesia associated with typical antipsychotics.
Glazer WM
J Clin Psychiatry; 2000; 61 Suppl 4():15-20. PubMed ID: 10739326
[TBL] [Abstract][Full Text] [Related]
9. Clinical and epidemiologic aspects of tardive dyskinesia.
Baldessarini RJ
J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):8-13. PubMed ID: 2858483
[TBL] [Abstract][Full Text] [Related]
10. A prospective study of tardive dyskinesia development: preliminary results.
Kane JM; Woerner M; Weinhold P; Wegner J; Kinon B
J Clin Psychopharmacol; 1982 Oct; 2(5):345-9. PubMed ID: 6127353
[TBL] [Abstract][Full Text] [Related]
11. Organic brain dysfunction and cognitive deficits in young schizophrenic patients with tardive dyskinesia.
Pourcher E; Cohen H; Cohen D; Baruch P; Bouchard RH
Brain Cogn; 1993 Sep; 23(1):81-7. PubMed ID: 8105825
[TBL] [Abstract][Full Text] [Related]
12. Incidence and persistence of tardive dyskinesia and extrapyramidal symptoms in schizophrenia.
Tenback DE; van Harten PN; Slooff CJ; van Os J
J Psychopharmacol; 2010 Jul; 24(7):1031-5. PubMed ID: 19487321
[TBL] [Abstract][Full Text] [Related]
13. Tardive dyskinesia: prevalence, incidence, and risk factors.
Kane JM; Woerner M; Lieberman J
J Clin Psychopharmacol; 1988 Aug; 8(4 Suppl):52S-56S. PubMed ID: 3065365
[TBL] [Abstract][Full Text] [Related]
14. Risk of tardive dyskinesia in older patients. A prospective longitudinal study of 266 outpatients.
Jeste DV; Caligiuri MP; Paulsen JS; Heaton RK; Lacro JP; Harris MJ; Bailey A; Fell RL; McAdams LA
Arch Gen Psychiatry; 1995 Sep; 52(9):756-65. PubMed ID: 7654127
[TBL] [Abstract][Full Text] [Related]
15. Worsening of psychosis in schizophrenia is longitudinally associated with tardive dyskinesia in the European Schizophrenia Outpatient Health Outcomes study.
Tenback DE; van Harten PN; Slooff CJ; van Os J;
Compr Psychiatry; 2007; 48(5):436-40. PubMed ID: 17707251
[TBL] [Abstract][Full Text] [Related]
16. A cross-sectional study of parkinsonism and tardive dyskinesia in lithium-treated affective disordered patients.
Ghadirian AM; Annable L; Bélanger MC; Chouinard G
J Clin Psychiatry; 1996 Jan; 57(1):22-8. PubMed ID: 8543543
[TBL] [Abstract][Full Text] [Related]
17. Preventing neuroleptic-induced tardive dyskinesia in adults and children.
Lam RW; Jeste SD; Jeste DV
Encephale; 1988 Sep; 14 Spec No():251-5. PubMed ID: 2905652
[TBL] [Abstract][Full Text] [Related]
18. Affective disorders and tardive dyskinesia.
Casey DE
Encephale; 1988 Sep; 14 Spec No():221-6. PubMed ID: 2905650
[TBL] [Abstract][Full Text] [Related]
19. The prevalence of tardive dyskinesia in geropsychiatric outpatients.
Chacko RC; Root L; Marmion J; Molinari V; Adams GL
J Clin Psychiatry; 1985 Feb; 46(2):55-7. PubMed ID: 2857168
[TBL] [Abstract][Full Text] [Related]
20. Substance abuse as a risk factor for tardive dyskinesia: a retrospective analysis of 1,027 patients.
Bailey LG; Maxwell S; Brandabur MM
Psychopharmacol Bull; 1997; 33(1):177-81. PubMed ID: 9133772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
